Quality of life and behavioral follow-up study of Head Start I pediatric brain tumor survivors

被引:0
作者
Stephen A. Sands
Keith P. Pasichow
Rebecca Weiss
James Garvin
Sharon Gardner
Ira J. Dunkel
Jonathan L. Finlay
机构
[1] Columbia University College of Physicians and Surgeons,Departments of Pediatrics and Psychiatry
[2] Steven and Alexandra Cohen Children’s Medical Center of New York,Department of Pediatrics
[3] North Shore—Long Island Jewish Health System,Department of Psychology
[4] Fordham University,Department of Pediatrics
[5] Columbia University College of Physicians and Surgeons,Department of Pediatrics
[6] NYU School of Medicine,Department of Pediatrics
[7] Memorial Sloan Kettering Cancer Center,Department of Pediatrics, Children’s Center for Cancer and Blood Diseases, Children’s Hospital Los Angeles and the Keck School of Medicine
[8] University of Southern California School of Medicine,Herbert Irving Child and Adolescent Oncology Center
[9] Columbia University College of Physicians and Surgeons,undefined
来源
Journal of Neuro-Oncology | 2011年 / 101卷
关键词
Quality of life; Late effects; Social–emotional; Behavioral; Pediatric brain tumor; Head Start;
D O I
暂无
中图分类号
学科分类号
摘要
To evaluate the Quality of Life (QoL) and Social–Emotional/Behavioral functioning of survivors treated on the “Head Start I” protocol at participating medical centers across the United States between 1991 and 1997. Parents of 25 of 27 (92.5%) patients completed the Child Health Questionnaire PF-50 (CHQ), to assess their child’s QoL, along with the Behavior Assessment System for Children (BASC), to assess their social–emotional/behavioral functioning, after a mean follow-up of 5.7 years (range 13–96 months). Nineteen (76%) of the 25 parents subsequently completed the same instruments after a mean of 11.6 years (range 90–181 months), three (12%) patients died of disease and three (12%) were lost to follow-up. Mean Physical and Psychosocial QoL Summary Scores on the CHQ at Time 1 (T1) and Time 2 (T2) were within the normal range. Of the ten individual means for CHQ subscales, nine were within normal limits with the exception of Parental Emotional Impact at T1 and General Health at T2. Additionally, mean scores on the BASC at T1 and T2 were within normal limits for Externalizing and Internalizing Behaviors as well as Adaptive Skills. Serial analyses between T1 and T2 revealed non-significant changes over time with the exception of decreased General Health on the CHQ. The lack of QoL and Social–Emotional/Behavioral deficits suggests that the Head Start I protocol, involving intensive induction followed by myeloablative chemotherapy and autologous hematopoietic cell rescue in order to avoid or delay cranial irradiation, provides encouraging pilot data warranting continued monitoring.
引用
收藏
页码:287 / 295
页数:8
相关论文
共 108 条
[1]  
Cella DF(1995)Measuring quality of life: 1995 update Oncology (Williston Park) 9 47-60
[2]  
Bonomi AE(1997)Psychological functioning of adolescent and young adult survivors of pediatric malignancy Med Pediatr Oncol 29 582-588
[3]  
Elkin TD(2005)Psychosocial functioning in pediatric cancer J Pediatr Psychol 30 9-27
[4]  
Phipps S(1999)Social, emotional, and behavioral functioning of children with cancer Pediatrics 103 71-78
[5]  
Mulhern RK(2003)A controlled longitudinal study of the social functioning of children who completed treatment of cancer J Pediatr Hematol/Oncol 25 467-473
[6]  
Fairclough D(2003)Psychosocial and behavioral functioning among pediatric brain tumor survivors J Neurooncol 63 279-287
[7]  
Patenaude AF(2002)Treatment, age, and time-related predictors of behavioral outcome in pediatric brain tumor survivors J Clin Psychol Med Settings 9 315-321
[8]  
Kupst MJ(1999)Health-related quality of life in childhood cancer: discrepancy in parent-child reports Int J Cancer 22 58-64
[9]  
Noll RB(2000)Social skills and psychological adjustment of child and adolescent cancer survivors Psycho-oncology 9 113-126
[10]  
Gartstein MA(2009)Health-related quality of life in long-term survivors of childhood brain tumors Pediatr Blood Cancer 53 1086-1091